When does science stop and drug development start?

Level up your industry engagement and commercialisation skills with PD+ Webinars

Join the first in our Life Sciences webinars that explores what is involved in the process of drug development on campus and asks: What is the difference between basic medical research and drug development? How does one lead to the other, and what else is involved?

What you'll learn:  

• The continuum from research to drug development
• Necessary discovery and development steps
• Clinical research - what regulators want
• IP protection and publishing
• Partnering to get your product to market

Who should attend

• PhD students
• Postdoctoral researchers
• Early and mid-career researchers
• Industry-engaged academics
• Industry-engaged professional staff

What you'll experience

PD+ is a free weekly webinar series that takes place every Friday from 12-1 PM. It is the perfect way to lunch and level up your industry engagement and commercialisation skills.

Meet your presenter: Dr Elane Zelcer

Dr Elane Zelcer is a leader in the healthtech (biotech, medtech, digital health) sector. She has more than 25 years’ experience as an advisor to startup and early stage companies, university & MRI spin-outs and research teams, with guidance for capital raising and commercialisation including risk management and governance. Her career spans director, scientific advisory board, executive management, management consulting, start-up founder and research roles, almost exclusively focused on healthtech. Elane is Deputy Chair of BioMelbourne Network, Director with AllergyPal, Director of her own company, BioConsult and a member of the scientific advisory board of AUSiMED (Australia Israel Medical Research).

Dr Zelcer's focus is the intersection between business and the research sector where she uses her knowledge and skills to assist startup/early stage companies and research based organisations to develop novel, value-add healthtech products. Dr Zelcer’s BSc (Hons), PhD & Grad Dip Mktg are from Monash University, and she completed post-doctoral studies at McMaster University, Hamilton, Ontario, Canada and the University of Virginia, Charlottesville, Virginia, USA. In 2017 she was awarded the Distinguished Alumni Award by Monash’s Faculty of Science, and is a Fellow of the Australian Institute of Company Directors.

PD+ streams: MedTech and Life Sciences | Commercialisation of Research

Register

Event is free by registration is essential

The PD+ webinar series is brought to you by the University of Newcastle's Knowledge Exchange and Enterprise (KEE) and Campus Plus.  Find out about upcoming PD+ webinars and catch up on recordings of previous PD+ webinars at the Research Advantage Knowledge Hub.

=================

What is KEE?

The University of Newcastle's Knowledge Exchange and Enterprise (KEE) is responsible for facilitating impact within our regions through intellectual property commercialisation, business development, and entrepreneurship. KEE works with researchers and industry to identify and facilitate high-value licenses and research collaborations, in addition to supporting pre-startups, startups, and scale-up companies.

=================